DAHMA: China Life Insurance (02628.HK) outperformed its peers in multiple data, with strong growth in new business value.

According to the financial news app, Zhongtong Finance, Morgan Stanley released a research report stating that China Life Insurance (02628.HK) has announced the third quarter net profit, with the highest profit growth among its peers, increasing by 60.5% in the first nine months of this year. This means that the annual ROE for the third quarter and the first nine months were 88.3% and 39.4% respectively. The company's new business value growth in the first nine months accelerated to 41.8% compared to 20.3% in the first half of the year. Morgan Stanley believes that China Life's performance in various data is superior to most of its peers, and the management has a positive outlook for the company next year. The firm set a target price of HK$25.7 for the company and rated it as "hold".